A. Rizzi

发表

Ala scan analogues of HOE 140. Synthesis and biological activities.

A Rizzi, D Regoli, C. Maggi, 2000, European journal of medicinal chemistry.

Receptors for kinins in the human isolated umbilical vein

A. Pizard, A. Rizzi, D. Regoli, 1996, British journal of pharmacology.

Human vascular kinin receptors of the B2 type characterized by radioligand binding

G. Calo’, G. Mollica, S. Gessi, 1997, British journal of pharmacology.

MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.

C. Maggi, G. Calo’, M. Criscuoli, 1999, The Journal of pharmacology and experimental therapeutics.

Structure–activity relationship study on human urotensin II

S. Salvadori, G. Calo’, R. Guerrini, 2005, Journal of peptide science : an official publication of the European Peptide Society.

A new ligand for the urotensin II receptor

E. Kostenis, S. Salvadori, G. Calo’, 2002, British journal of pharmacology.

Nociceptin/orphanin FQ receptor ligands

S. Salvadori, G. Calo’, R. Guerrini, 2000, Peptides.

Urotensin II stimulates plasma extravasation in mice via UT receptor activation

S. Salvadori, G. Calo’, R. Guerrini, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

E. Kostenis, G. Calo’, P. Zamboni, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Glutamic Acid Decarboxylase-positive Neuronal Cell Bodies and Terminals in the Human Cerebellar Cortex

J. Bormann, P. Monaghan, L. Roncali, 2000, The Histochemical Journal.

Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.

G. Calo’, A. Rizzi, D. Regoli, 1996, Life sciences.

Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity.

C. Ghelardini, G. Calo’, L. Micheli, 2015, European journal of pharmacology.

Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.

S. Salvadori, D. Lambert, G. Calo’, 2009, European journal of pharmacology.

B1 and B2 kinin receptors in various species.

G. Calo’, A. Rizzi, D. Regoli, 1997, Immunopharmacology.

Angiogenesis versus arteriogenesis.

D. Ribatti, A. Rizzi, V. Benagiano, 2017, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

The functional anatomy of the cerebrocerebellar circuit: A review and new concepts

D. Ribatti, L. Roncali, P. Flace, 2018, The Journal of comparative neurology.

Endogenous nociceptin signaling and stress-induced analgesia

S. Salvadori, J. Mogil, G. Calo’, 2001, Neuroreport.

Non-traditional large neurons in the granular layer of the cerebellar cortex.

L. Roncali, P. Flace, F. Girolamo, 2007, European journal of histochemistry : EJH.

Classification of Kinin Receptors

A. Rizzi, D. Regoli, F. Gobeil, 2001, Biological chemistry.

Antagonistic effects of FR 173657 on human, pig, rabbit, and guinea pig kinin receptors: an in vitro study.

G. Calo’, C. Campobasso, N. Inamura, 1997, Canadian journal of physiology and pharmacology.

In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN11270

C. Maggi, A. Lecci, L. Quartara, 2002 .

Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors)

G. Calo’, C. Campobasso, G. Mollica, 1996, Regulatory Peptides.

Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems

G. Calo’, S. Amadesi, A. Rizzi, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors

K. Varani, G. Calo’, N. Inamura, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.

G. Calo’, N. Inamura, A. Rizzi, 1997, Hypertension.

Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus.

L. Fabbri, S. Salvadori, G. Calo’, 1999, Life sciences.

Pharmacological Profile Of Nociceptin/Orphanin Fq Receptors

S. Salvadori, G. Calo’, R. Guerrini, 2002, Clinical and experimental pharmacology & physiology.

Spinal antinociceptive effects of the novel NOP receptor agonist PWT2‐nociceptin/orphanin FQ in mice and monkeys

C. Ruzza, G. Calo’, R. Guerrini, 2015, British journal of pharmacology.

In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives

S. Salvadori, D. Lambert, C. Ruzza, 2014, British journal of pharmacology.

Pharmacological characterization of tachykinin tetrabranched derivatives

C. Ruzza, G. Calo’, R. Guerrini, 2014, British journal of pharmacology.

Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor

S. Salvadori, G. Calo’, R. Guerrini, 2010, Medicinal research reviews.

Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues

S. Salvadori, D. Lambert, G. Calo’, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.

S. Salvadori, P. Temussi, G. Calo’, 1997, Journal of medicinal chemistry.

GABA Immunoreactivity in the Human Cerebellar Cortex: A Light and Electron Microscopical Study

J. Bormann, L. Roncali, P. Flace, 2001, The Histochemical Journal.

Immunolocalization of glutamic acid decarboxylase in postmortem human cerebellar cortex. A light microscopy study

L. Roncali, P. Flace, D. Virgintino, 2000, Histochemistry and Cell Biology.

In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.

C. Ruzza, G. Calo’, R. Guerrini, 2016, European journal of pharmacology.

Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.

S. Salvadori, D. Lambert, G. Calo’, 2009, Bioorganic & medicinal chemistry.

Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In Vivo Studies

R. Ciccocioppo, G. Calo’, C. Trapella, 2007, Journal of Pharmacology and Experimental Therapeutics.

D. Lambert, M. Morari, G. Calo’, 2007, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological characterization of the nociceptin / orphanin FQ receptor antagonist SB-612111: in vivo studies

D. Lambert, M. Morari, G. Calo’, 2007 .

Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies

S. Salvadori, K. Varani, G. Calo’, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships

S. Salvadori, K. Varani, G. Calo’, 1998, British journal of pharmacology.

Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test

C. Ruzza, G. Calo’, C. Trapella, 2017, Peptides.

[Dmt1]N/OFQ(1–13)‐NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist

S. Salvadori, D. Lambert, P. Molinari, 2012, British journal of pharmacology.

Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.

G. Calo’, B. Battistini, A. Rizzi, 1998, Journal of cardiovascular pharmacology.

Characterization of endothelin receptors in the human umbilical artery and vein

G. Calo’, C. Campobasso, A. Rizzi, 1996, British journal of pharmacology.

Pharmacological characterization of nociceptin receptor: an in vitro study.

S. Salvadori, G. Calo’, R. Guerrini, 1997, Canadian journal of physiology and pharmacology.

Pharmacological studies on the NOP and opioid receptor agonist PWT2‐[Dmt1]N/OFQ(1‐13)

D. Lambert, C. Ruzza, G. Calo’, 2017, European journal of pharmacology.

A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ.

S. Salvadori, G. Calo’, R. Guerrini, 2014, Bioorganic & medicinal chemistry.

Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.

S. Salvadori, K. Varani, D. Lambert, 2000, Journal of medicinal chemistry.

In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist

D. Lambert, G. Calo’, R. Guerrini, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist

S. Salvadori, D. Lambert, G. Calo’, 2000, British journal of pharmacology.

Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences

G. Calo’, Cristiano Nazzaro, H. Zeilhofer, 2006, Pain.

VIP-like immunoreactivity within neurons and perivascular neuronal processes of the human cerebral cortex.

E. Maiorano, L. Roncali, D. Virgintino, 1996, European journal of histochemistry : EJH.

Involvement of the N/OFQ‐NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?

C. Ghelardini, R. Ciccocioppo, G. Calo’, 2018, European journal of pharmacology.

Blockade of Nociceptin/orphanin Fq Receptor Signaling in Rat Substantia Nigra Pars Reticulata Stimulates Nigrostriatal Dopaminergic Transmission and Motor Behavior ,lys 15 ]n/ofq(1–13)-nh 2 ) (a Selective Nop Receptor Peptide Antagonist) Stimulated It. N/ofq Microinjected in the Sub- Stantia Nigra P

N. Mercuri, G. Franchi, S. Salvadori, 2022 .

Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice

S. Salvadori, G. Calo’, R. Guerrini, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Structure-Activity Studies on Neuropeptide S

S. Salvadori, C. Corti, G. Calo’, 2006, Journal of Biological Chemistry.

The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.

V. Neugebauer, S. Salvadori, G. Calo’, 1996, European journal of pharmacology.

Pharmacological characterisation of novel kinin B2 receptor ligands.

G. Calo’, A. Rizzi, D. Regoli, 2002, Canadian Journal of Physiology and Pharmacology.

Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.

C. Ghelardini, R. Ciccocioppo, G. Calo’, 2015, European journal of pharmacology.

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist

C. Ruzza, G. Calo’, R. Guerrini, 2016, Pharmacology research & perspectives.

UFP‐112 a Potent and Long‐Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor

Maurizio Massi, Remo Guerrini, Girolamo Calo', 2011, CNS neuroscience & therapeutics.

Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies

G. Calo’, A. Rizzi, M. Marti, 2011, Neuropharmacology.

In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor

S. Salvadori, G. Calo’, R. Guerrini, 2007, Peptides.

Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay

S. Salvadori, G. Calo’, L. Beani, 1998, British journal of pharmacology.

Bradykinin receptors and their antagonists.

A. Rizzi, D. Regoli, F. Gobeil, 1998, European journal of pharmacology.

Characterization of FR 172357, a new non-peptide bradykinin B(2) receptor antagonist, in human, pig and rabbit preparations.

G. Calo’, G. Mollica, N. Inamura, 1999, European journal of pharmacology.

Calbindin‐D28K Immunoreactivity in the Human Cerebellar Cortex

D. Ribatti, B. Nico, P. Flace, 2014, Anatomical record.

Pharmacology of nociceptin and its receptor: a novel therapeutic target

S. Salvadori, G. Calo’, R. Guerrini, 2000, British journal of pharmacology.

[Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.

S. Salvadori, G. Calo’, R. Guerrini, 1999, European journal of pharmacology.

VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex

Domenico Ribatti, D. Ribatti, B. Nico, 2011, BMC Neuroscience.

In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant

G. Calo’, C. Pietra, A. Rizzi, 2012, Peptides.

In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.

F. Simonin, B. Kieffer, G. Calo’, 2000, Life sciences.

Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies

C. Maggi, S. Salvadori, G. Calo’, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

A new selective antagonist of the nociceptin receptor

S. Salvadori, G. Calo’, R. Guerrini, 1998, British journal of pharmacology.

In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant

C. Giuliano, C. Ruzza, G. Calo’, 2015, Peptides.

Studies on the antinociceptive effect of [Nphe1]nociceptin(1–13)NH2 in mice

R. Bertorelli, S. Salvadori, G. Calo’, 2001, Neuroscience Letters.

The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1‐13)NH2, potentiates morphine analgesia

S. Salvadori, G. Calo’, R. Guerrini, 2000, Neuroreport.

Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor

C. Ruzza, G. Calo’, R. Guerrini, 2012, Neuropharmacology.

Effects of vasoactive agents in healthy and diseased human saphenous veins.

G. Calo’, P. Zamboni, F. Mascoli, 1998, Journal of vascular surgery.

Vasoactive intestinal polypeptide immunoreactivity in the human cerebellum: qualitative and quantitative analyses

P. Flace, A. Rizzi, R. Cagiano, 2009, Journal of anatomy.

Is The Cerebellum Involved In The Nervous Control Of The Immune System Function?

A. Rizzi, V. Benagiano, M. Saccia, 2019, Endocrine, metabolic & immune disorders drug targets.

Further data on the development of SRIF-like immunoreactive nerve cell populations in the chick embryo brain stem. I. Medulla and pons.

G. Nicolardi, A. Rizzi, R. Arena, 1992, Bollettino della Societa italiana di biologia sperimentale.

Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex

P. Flace, F. Girolamo, A. Rizzi, 2007, Neuroscience.

Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A

S. Salvadori, G. Calo’, R. Guerrini, 2000, Peptides.

Pharmacology of the kallikrein-kinin system.

G. Calo’, A. Rizzi, D. Regoli, 1997, Pharmacological research.

Glutamic acid decarboxylase immunoreactive large neuron types in the granular layer of the human cerebellar cortex

L. Roncali, P. Flace, F. Girolamo, 2004, Anatomy and Embryology.

Mast cells in human digestive tube in normal and pathological conditions.

E. Crivellato, D. Ribatti, A. Rizzi, 2016, Immunology letters.

Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice

G. Calo’, B. Larsen, A. Rizzi, 2002, British journal of pharmacology.

Anxiolytic‐ and panicolytic‐like effects of Neuropeptide S in the mouse elevated T‐maze

C. Ruzza, G. Calo’, R. Guerrini, 2012, The European journal of neuroscience.

Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68

S. Salvadori, C. Cifani, R. Ciccocioppo, 2010, Peptides.

In Vitro and in Vivo Pharmacological Characterization of the Neuropeptide S Receptor Antagonist [d-Cys(tBu)5]Neuropeptide S

S. Salvadori, R. Reinscheid, C. Ruzza, 2009, Journal of Pharmacology and Experimental Therapeutics.

Anxiolytic-like effect of neuropeptide S in the rat defensive burying

G. Calo’, R. Guerrini, M. Filaferro, 2008, Peptides.

Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice

S. Salvadori, C. Ruzza, G. Calo’, 2008, British journal of pharmacology.

[Nphe1,Arg14,Lys15]Nociceptin‐NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor

S. Salvadori, D. Lambert, M. Morari, 2002, British journal of pharmacology.

In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative

S. Salvadori, R. Reinscheid, C. Ruzza, 2015, Pharmacology research & perspectives.

In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1

R. Reinscheid, C. Ruzza, G. Calo’, 2013, Peptides.

[ t Bu-d-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies

S. Salvadori, C. Ruzza, G. Calo’, 2012, Peptides.

Synthesis and biological activity of human neuropeptide S analogues modified in position 5

S. Salvadori, R. Reinscheid, G. Calo’, 2010 .

Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

S. Salvadori, R. Reinscheid, C. Ruzza, 2009, Journal of medicinal chemistry.

Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.

S. Salvadori, R. Reinscheid, C. Ruzza, 2009, Journal of medicinal chemistry.

Structure-activity study at positions 3 and 4 of human neuropeptide S.

S. Salvadori, R. Reinscheid, C. Ruzza, 2008, Bioorganic & medicinal chemistry.

In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [ D-Cys ( tBu ) 5 ] NPS

S. Salvadori, R. Reinscheid, C. Ruzza, 2008 .

Synthesis and biological activity of human neuropeptide S analogues modified in position 2.

S. Salvadori, R. Reinscheid, C. Ruzza, 2008, Journal of medicinal chemistry.

Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120

G. Calo’, R. Guerrini, C. Trapella, 2009, Peptides.

In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.

A. Magyar, G. Calo’, L. Kocsis, 2006, European journal of pharmacology.

Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.

S. Salvadori, G. Calo’, R. Guerrini, 1998, Journal of medicinal chemistry.

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

M. Zaniboni, G. Rossoni, G. Villetti, 2010, Journal of Pharmacology and Experimental Therapeutics.

CHF 5407 ) a Potent , Long-Acting and Selective Muscarinic M 3 Receptor Antagonist

G. Villetti, M. Civelli, F. Pastore, 2010 .

Microsoft Word - 1192223-file00

M. Zaniboni, M. Civelli, F. Pastore, 2010 .

Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.

S. Salvadori, G. Calo’, R. Guerrini, 2002, Life sciences.

UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.

S. Salvadori, D. Lambert, G. Calo’, 2006, CNS drug reviews.

UFP-101, a Peptide Antagonist Selective for the Nociceptin (cid:1) Orphanin FQ Receptor

S. Salvadori, D. Lambert, G. Calo’, 2005 .

Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors

S. Salvadori, C. Ruzza, G. Calo’, 2018, Peptides.

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor

S. Salvadori, D. Lambert, M. Morari, 2005, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues

M. Salis, S. Salvadori, R. Ciccocioppo, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[Arg14,Lys15]Nociceptin, a Highly Potent Agonist of the Nociceptin/Orphanin FQ Receptor: in Vitro and in Vivo Studies

G. Calo’, R. Guerrini, C. D. Risi, 2002 .

Girolamo Calo ’ Pharmacological characterisation of [ ( pX ) Phe 4 ] nociceptin ( 1-13 ) amide analogues 1 . In vitro studies

Hartmut Berger, Remo Guerrini, Girolamo Calo', 2002 .

Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.

S. Salvadori, K. Varani, D. Lambert, 2001, Journal of medicinal chemistry.

UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: Behavioral and electrophysiological studies in mice

S. Salvadori, G. Calo’, Cristiano Nazzaro, 2007, Peptides.

Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.

D G Lambert, R Bigoni, G Caò, 2002, Canadian journal of physiology and pharmacology.

[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.

G. Calo’, R. Guerrini, C. De Risi, 2002, The Journal of pharmacology and experimental therapeutics.

Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues

G. Calo’, R. Guerrini, A. Rizzi, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice

G. Calo’, S. Zucchini, A. Rizzi, 2007, Peptides.

A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow.

D. Guidolin, D. Ribatti, C. Tortorella, 2015, Experimental cell research.

Distribution of Multilayered Fiber Terminals in the Human Cerebellar Cortex. Visualization by Immunohistochemistry for Histamine

A. Rizzi, V. Benagiano, M. Saccia, 2019, Online Journal of Neurology and Brain Disorders.

Pharmacological characterization of nociceptin receptor: an in vitro study.

S. Salvadori, G. Calo’, R. Guerrini, 1997, Canadian journal of physiology and pharmacology.

Synthesis and pharmacological activity of a new antagonist of the OP4 receptor

S. Salvadori, G. Calo’, R. Guerrini, 2002 .

Pharmacology letters Accelerated communication In vitro pharmacological profile of peptide III-BTD A novel ligand for nociceptin/orphanin FQ and opioid receptors

F. Simonin, G. Calo’, A. Rizzi, 2000 .

Blockade of Nociceptin/Orphanin FQ Receptor Signaling in Rat Substantia Nigra Pars Reticulata Stimulates Nigrostriatal Dopaminergic Transmission and Motor Behavior

N. Mercuri, G. Franchi, S. Salvadori, 2004, The Journal of Neuroscience.

Spinal antinociceptive effects of the novel NOP receptor agonist PWT2‐nociceptin/orphanin FQ in mice and monkeys

C. Ruzza, R. Guerrini, A. Rizzi, 2015, British journal of pharmacology.

Cholinergic nerve fibres associated with the microvessels of the human cerebral cortex: a study based on monoclonal immunocytochemistry for choline acetyltrasferase.

L. Roncali, M. Errede, D. Virgintino, 2000, European journal of histochemistry : EJH.